Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03564353 · ClinicalTrials.gov registry record · NA

Investigating Memory in Healthy Subjects Using Transcranial Direct Current Stimulation

A NA study, sponsored by The University of Texas at Dallas.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT03564353: Completed NA study, sponsored by The University of Texas at Dallas.

NCT03564353 is a NA study that has completed, run by The University of Texas at Dallas. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03564353, a NA study, has completed, sponsored by The University of Texas at Dallas.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The purpose of this study is to investigate whether we can improve associative memory performance in healthy subjects, by applying transcranial Direct Current Stimulation (tDCS) during a verbal paired-associate learning task

Primary Outcome

Participants got the opportunity to learn the list of 75-word pairs across a total of eight alternating study (S) and test (T) periods. Participants came back for a final test session (all 75 words tested) 7 days later and were asked to give the English translations of Swahili words. A score was calaculated based on the percentage of words (English trnaslations) correctly recalled words.

Interventions

  • DEVICE tDCS

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-06-07
Est. Completion 2022-01-25
Phase NA
The University of Texas at Dallas

50 total trials

What the finished NCT03564353 record still lists

NCT03564353 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which tDCS is the first listed.

NCT03564353 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03564353 about?

NCT03564353 is a clinical study titled "Investigating Memory in Healthy Subjects Using Transcranial Direct Current Stimulation". The purpose of this study is to investigate whether we can improve associative memory performance in healthy subjects, by applying transcranial Direct Current Stimulation (tDCS) during a verbal paired-associate learning task

What is the current status of trial NCT03564353?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-06-07. Estimated completion is 2022-01-25.

What interventions are being tested in trial NCT03564353?

The interventions under investigation include: tDCS (DEVICE).

Who is sponsoring clinical trial NCT03564353?

This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03564353's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03564353, the US trial registry maintained by the National Library of Medicine. NCT03564353 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.